Ontology highlight
ABSTRACT: Objective
To investigate whether vitamin D and marine derived long chain omega 3 fatty acids reduce autoimmune disease risk.Design
Vitamin D and omega 3 trial (VITAL), a nationwide, randomized, double blind, placebo controlled trial with a two-by-two factorial design.Setting
Nationwide in the United States.Participants
25 871 participants, consisting of 12 786 men ≥50 years and 13 085 women ≥55 years at enrollment.Interventions
Vitamin D (2000 IU/day) or matched placebo, and omega 3 fatty acids (1000 mg/day) or matched placebo. Participants self-reported all incident autoimmune diseases from baseline to a median of 5.3 years of follow-up; these diseases were confirmed by extensive medical record review. Cox proportional hazard models were used to tes
SUBMITTER: Hahn J
PROVIDER: S-EPMC8791065 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature